LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...

"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...